+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Inhalation & Nasal Sprays Generic Drugs Market by Route of Administration, Patient Age Group, Formulation, Distribution Channel, End User - Global Forecast to 2030- Product Image
Inhalation & Nasal Sprays Generic Drugs Market by Route of Administration, Patient Age Group, Formulation, Distribution Channel, End User - Global Forecast to 2030- Product Image
Sale

Inhalation & Nasal Sprays Generic Drugs Market by Route of Administration, Patient Age Group, Formulation, Distribution Channel, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5014109
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Inhalation & Nasal Sprays Generic Drugs Market is undergoing considerable transformation, influenced by evolving respiratory health needs and demanding operational environments. Senior executives in pharmaceuticals and healthcare supply chains face reshaped imperatives around cost, quality, and regulatory adaptation amid ongoing shifts in device technology and international trade policies.

Market Snapshot: Inhalation & Nasal Sprays Generic Drugs Market

The Inhalation & Nasal Sprays Generic Drugs Market grew from USD 8.78 billion in 2024 to USD 9.56 billion in 2025. It is expected to continue growing at a CAGR of 8.64%, reaching USD 14.44 billion by 2030. Key growth drivers include the expiration of patents on leading respiratory therapeutics, rapid advances in inhaler and nasal spray delivery systems, and supportive regulatory moves promoting affordable generic access globally. Increased demand and adoption of advanced drug-device combinations are reshaping competitive positioning and strategy among prominent generics manufacturers.

Scope & Segmentation

  • Route of Administration: Inhalation (dry powder inhalers, metered dose inhalers, nebulizers, soft mist inhalers); Nasal (powder, spray)
  • Therapeutic Class: Bronchodilators, combination therapies, corticosteroids, antihistamines, decongestants
  • Patient Age Group: Adult, pediatric, geriatric
  • Formulation Types: Dry powder, solution, suspension
  • Distribution Channels: Hospital pharmacy, online pharmacy, retail pharmacy
  • End Users: Ambulatory care, home care, hospitals
  • Regions: Americas, Europe, Middle East & Africa, Asia-Pacific (including detailed country and state coverage)
  • Technological Innovations: Breath-actuated devices, digital health integrations, advanced micronization and drug-device combinations
  • Key Companies Analyzed: Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, Viatris Inc, Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr. Reddy’s Laboratories Ltd, Lupin Limited, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals, Inc, Glenmark Pharmaceuticals Ltd

Key Takeaways for Senior Decision-Makers

  • Patent expirations are giving rise to a new wave of generic entrants, challenging traditional branded product dominance and expanding patient access.
  • Consolidation among generics manufacturers and alliances with device specialists are driving operational scale and technological sophistication.
  • Regulatory frameworks have increasingly streamlined approval for complex generics, requiring investment in equivalence studies and advanced testing.
  • Integration of digital health tools, such as smart inhaler attachments and adherence apps, provides an edge through value-added patient services.
  • Regional and local supply chain resilience is emerging as a critical strategy to address international trade barriers and fluctuating raw material costs.
  • Targeted product adaptations accommodate distinct age groups and care environments, supporting broader market penetration.

Tariff Impact on Inhalation & Nasal Generics

Increased US tariffs on pharmaceutical imports are prompting manufacturers to enhance domestic production capabilities and diversify sourcing arrangements. Larger companies benefit from localizing their supply chains, supporting cost control, and minimizing inventory disruptions. These moves help mitigate profit margin pressures and operational risk, especially as payers place additional scrutiny on pricing and formulary value. The overall market is adapting through reassessment of supplier networks, increased investment in contract manufacturing partnerships, and adoption of digital platforms to improve supply chain transparency.

Methodology & Data Sources

This analysis combines in-depth secondary research—including regulatory review, patent mapping, and tariff tracking—with primary insights from senior industry executives, payers, and device specialists. Quantitative validation utilizes market intelligence databases and benchmarking of key product pipelines, ensuring segment trends reflect real-world growth drivers and risks.

Why This Report Matters

  • Delivers a comprehensive review of next-generation device innovation, regulatory trends, and market dynamics guiding investment and portfolio management.
  • Offers region-by-region and segment-specific strategic recommendations, supporting executive decision-making in product launches and channel optimization.
  • Equips senior leaders with the competitive intelligence required to strengthen positioning amid tariff changes and technological convergence in respiratory generics.

Conclusion

The generics inhalation and nasal spray market demands agile leadership and informed, forward-looking strategies. Companies able to adapt through both portfolio innovation and supply chain resilience will be best positioned for long-term growth and sustainable value creation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Inhalation & Nasal Sprays Generic Drugs Market, by Route of Administration
8.1. Introduction
8.2. Inhalation
8.2.1. Dry Powder Inhaler
8.2.1.1. Bronchodilator
8.2.1.2. Combination
8.2.1.3. Corticosteroid
8.2.2. Metered Dose Inhaler
8.2.2.1. Bronchodilator
8.2.2.2. Combination
8.2.2.3. Corticosteroid
8.2.3. Nebulizer
8.2.3.1. Bronchodilator
8.2.3.2. Corticosteroid
8.2.4. Soft Mist Inhaler
8.2.4.1. Bronchodilator
8.2.4.2. Combination
8.2.4.3. Corticosteroid
8.3. Nasal
8.3.1. Powder
8.3.1.1. Antihistamine
8.3.1.2. Corticosteroid
8.3.1.3. Decongestant
8.3.2. Spray
8.3.2.1. Antihistamine
8.3.2.2. Corticosteroid
8.3.2.3. Decongestant
9. Inhalation & Nasal Sprays Generic Drugs Market, by Patient Age Group
9.1. Introduction
9.2. Adult
9.3. Geriatric
9.4. Pediatric
10. Inhalation & Nasal Sprays Generic Drugs Market, by Formulation
10.1. Introduction
10.2. Dry Powder
10.3. Solution
10.4. Suspension
11. Inhalation & Nasal Sprays Generic Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Inhalation & Nasal Sprays Generic Drugs Market, by End User
12.1. Introduction
12.2. Ambulatory Care
12.3. Home Care
12.4. Hospital
13. Americas Inhalation & Nasal Sprays Generic Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Inhalation & Nasal Sprays Generic Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Inhalation & Nasal Sprays Generic Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Teva Pharmaceutical Industries Ltd
16.3.2. Sandoz International GmbH
16.3.3. Viatris Inc
16.3.4. Sun Pharmaceutical Industries Ltd
16.3.5. Cipla Ltd
16.3.6. Dr. Reddy’s Laboratories Ltd
16.3.7. Lupin Limited
16.3.8. Hikma Pharmaceuticals PLC
16.3.9. Amneal Pharmaceuticals, Inc
16.3.10. Glenmark Pharmaceuticals Ltd
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET MULTI-CURRENCY
FIGURE 2. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY BRONCHODILATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COMBINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY BRONCHODILATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COMBINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY BRONCHODILATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY BRONCHODILATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COMBINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ANTIHISTAMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DECONGESTANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ANTIHISTAMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DECONGESTANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SPRAY, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SPRAY, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SPRAY, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 84. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 85. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 86. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 87. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 88. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 89. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, 2018-2030 (USD MILLION)
TABLE 90. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 91. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 92. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SPRAY, 2018-2030 (USD MILLION)
TABLE 93. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 94. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 95. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 99. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 100. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 101. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 102. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, 2018-2030 (USD MILLION)
TABLE 103. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 104. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 105. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SPRAY, 2018-2030 (USD MILLION)
TABLE 106. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 107. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 108. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SPRAY, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SPRAY, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SPRAY, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SPRAY, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 164. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 165. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 166. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 167. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 168. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, 2018-2030 (USD MILLION)
TABLE 169. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 170. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 171. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SPRAY, 2018-2030 (USD MILLION)
TABLE 172. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 173. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 174. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. FRANCE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. FRANCE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 178. FRANCE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 179. FRANCE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 180. FRANCE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 181. FRANCE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, 2018-2030 (USD MILLION)
TABLE 182. FRANCE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 183. FRANCE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 184. FRANCE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SPRAY, 2018-2030 (USD MILLION)
TABLE 185. FRANCE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 186. FRANCE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 187. FRANCE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. FRANCE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SPRAY, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 203. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 204. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 205. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 206. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 207. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, 2018-2030 (USD MILLION)
TABLE 208. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 209. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 210. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SPRAY, 2018-2030 (USD MILLION)
TABLE 211. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 212. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 213. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. SPAIN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 216. SPAIN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 217. SPAIN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 218. SPAIN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 219. SPAIN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 220. SPAIN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, 2018-2030 (USD MILLION)
TABLE 221. SPAIN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 222. SPAIN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 223. SPAIN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SPRAY, 2018-2030 (USD MILLION)
TABLE 224. SPAIN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 225. SPAIN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 226. SPAIN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. SPAIN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SPRAY, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SPRAY, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 252. SAUDI ARABIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SPRAY, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. SOUTH AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. DENMARK INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 268. DENMARK INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 269. DENMARK INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, 2018-2030 (USD MILLION)
TABLE 270. DENMARK INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, 2018-2030 (USD MILLION)
TABLE 271. DENMARK INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, 2018-2030 (USD MILLION)
TABLE 272. DENMARK INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, 2018-2030 (USD MILLION)
TABLE 273. DENMARK INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 274. DENMARK INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
TABLE 275. DENMARK INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SPRAY, 2018-2030 (USD MILLION)
TABLE 276. DENMARK INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 277. DENMARK INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 278. DENMARK INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. DENMARK INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Inhalation & Nasal Sprays Generic Drugs market report include:
  • Teva Pharmaceutical Industries Ltd
  • Sandoz International GmbH
  • Viatris Inc
  • Sun Pharmaceutical Industries Ltd
  • Cipla Ltd
  • Dr. Reddy’s Laboratories Ltd
  • Lupin Limited
  • Hikma Pharmaceuticals PLC
  • Amneal Pharmaceuticals, Inc
  • Glenmark Pharmaceuticals Ltd

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 9.56 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.44 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Inhalation and Nasal Spray Generic Drugs - Global Strategic Business Report - Product Image

Inhalation and Nasal Spray Generic Drugs - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Inhalation and Nasal Spray Generic Drugs Market Report 2025 - Product Image

Inhalation and Nasal Spray Generic Drugs Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Generic Drugs Market by Product Type, Drug Class, Route of Administration, Patient Type, Therapeutic Application, Distribution Channel - Global Forecast to 2030 - Product Image

Generic Drugs Market by Product Type, Drug Class, Route of Administration, Patient Type, Therapeutic Application, Distribution Channel - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Specialty Generics Market by Product Type, Drug Delivery System, Molecule Type, Disease Indication, Distribution Channel - Global Forecast to 2030 - Product Image

Specialty Generics Market by Product Type, Drug Delivery System, Molecule Type, Disease Indication, Distribution Channel - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
Generic Central Nervous System Drugs Market Report 2025 - Product Image

Generic Central Nervous System Drugs Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.